Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
about
Proteoglycans in liver cancerBMP9 is a proliferative and survival factor for human hepatocellular carcinoma cellsComparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumorsAntiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factorWSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signalingUp-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma.Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of Oncology.Diffusion-weighted imaging of a prostate cancer xenograft model seen on a 7 Tesla animal MR scanner: comparison of ADC values and pathologic findings.Chemokines and their receptors play important roles in the development of hepatocellular carcinomaHCC and angiogenesis: possible targets and future directionsHypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma.Hepatocellular cancer arises from loss of transforming growth factor beta signaling adaptor protein embryonic liver fodrin through abnormal angiogenesis.Bridging Sunitinib Exposure to Time-to-Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker.Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis.Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenibPotential roles of bone morphogenetic protein (BMP)-9 in human liver diseases.RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.On-line surface plasmon resonance biosensing of vascular endothelial growth factor signaling in intact-human hepatoma cell lines.Snail1-dependent transcriptional repression of Cezanne2 in hepatocellular carcinoma.Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma.Gene Expression Profiling of Hepatocellular Carcinoma Derived Cancer Stem Like Cell under Hypoxia.A validated, transitional and translational porcine model of hepatocellular carcinoma.Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells.Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective.Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.Cancer Patient-Derived Circulating Microparticles Enhance Lung Metastasis in a Rat Model: Dual-Source CT, Cellular, and Molecular Studies.Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective.Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cells.
P2860
Q26772304-FDAEA62F-5C90-416E-BD5E-5738B686A8DCQ28296361-5447ABEB-1E6E-42BF-81D8-DC150B8EBB9BQ33376925-1F0E36BC-3255-41F5-B898-D61F099B850FQ33798661-78D6731C-F224-44E4-BF03-B85B65935B6BQ33830807-D9AB1174-9F81-4802-BE91-3D810D08E33BQ34186700-5C66DD82-DABF-4001-AAE4-4AE28075F9B4Q34425709-EE0CCA65-207E-4611-81E2-DE55AE9E32ECQ35602256-82994976-1909-40C2-B5F8-497A572E15F4Q35659778-4C53284D-CA3F-44A6-B56D-C4CE3A562B8AQ35668771-D69157B7-847E-49DC-80E0-0D6FBB9EEEA0Q35698574-A67A4913-FC4A-4EC0-9BFE-793032191EA9Q36845140-3990E2F3-C04C-4BA8-990F-86B2250496C4Q37355553-DD2DB703-3AB0-42CD-9F34-52D4E6FEE53DQ37461714-59B02AF9-D555-4567-BE0C-5DD3EBC626AFQ37463744-D5BBDADD-0E93-41D0-AF67-EAD037D2B921Q37821302-842ADECC-B3EF-46C9-AF65-01E6C846A2A1Q38199567-911B6D3D-3DFC-4DC7-B121-4A5AEBEE857FQ38941114-ABEAC192-E38C-4C48-ACF2-5C6F7073E12AQ39028572-1D0D8ACE-A9B7-4EF4-A406-9A53D239ED85Q39136423-F5CB90E2-56E8-4D45-A964-E6C7B8C282B4Q39506866-4337723E-1351-4CA3-B216-139A80DE508FQ41352333-48733759-548D-4C72-B4B2-F33B85DCB004Q41985448-1C78C42F-89F8-4D09-B4AE-476E9435EDF4Q42001195-7C53271C-8723-4CB2-ABCA-493D83DAC901Q44697301-72CC47F9-4883-47DD-AC1B-0F068B452ACAQ48018285-154A664A-4249-4EC8-A8A7-3C86C7AA77E3Q51606004-C689947E-6B03-4776-B4FA-2E895C819B0BQ54180674-FB142120-E8B6-4AB7-9DED-9C77F2B531FEQ54652252-94B05CC0-039F-4218-BB5A-16E0AB42EE43
P2860
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
@ast
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
@en
type
label
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
@ast
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
@en
prefLabel
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
@ast
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
@en
P1476
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
@en
P2093
Hui-Chuan Sun
Zhao-You Tang
P2888
P304
P356
10.1007/S00432-003-0530-Y
P577
2004-03-18T00:00:00Z